Investigational Ultra-long-acting Insulin Degludec Reduces Rates of Nocturnal Hypoglycaemia in Type 2 Diabetes Patients Versus Insulin Glargine
-
2
pages
-
English
-
Documents
Publié par
novo-nordisk
-
2
pages
-
English
-
Documents
Description
Investigational Ultra-long-acting Insulin Degludec Reduces Rates of Nocturnal Hypoglycaemia in Type 2 Diabetes Patients Versus Insulin Glargine PR Newswire PHILADELPHIA, June 22, 2012 PHILADELPHIA, June 22, 2012 /PRNewswire/ -- Ultra-long-acting insulin degludec, an
-
Publié par
-
Langue
English
Ajouté à mes notifications
Vous serez informé des prochaines publications.